Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion.. The current share price is moving around the level announced in the acquisition agreement on August 2nd, 2020 ($175), which implies a market cap of approximately $16bn. The two firms aim at improving their position in the sector and consolidating an already existing partnership between the two companies. This includes personalizing content and advertising. Combines the Energy provided by Varian’s technology solutions and the Vision enabled by imaging excellence from Siemens. The Advanced Therapies and the Imaging segments have grown, while a slight decline has been reported for Diagnostics. Varian Medical Systems, Inc (NYSE: VAR) announced Sunday that Siemens Healthineers AG (OTC: SMMNY) would purchase it in an all-cash transaction valued at … We use cookies to understand how you use our site and to improve your experience. The partnership between Siemens and Varian provides access to the latest innovative technology and helps the medical community to increase the benefits for patients. The desired impact on the industry should be originated by a strong cultural fit between Varian and Siemens Healthineers, in terms of innovation and purpose-driven culture. Siemens spun off (of corporate action where a company “splits off” a section as a separate business) Siemens Healthineers in 2018 but retains an 85% stake in the business. Net income was 10% lower than the previous fiscal year amounting to €1,423 million. The companies announced that they will … Siemens Healthineers plans to acquire Varian to advance fight against cancer and strengthen its position in healthcare. The creation of a highly integrated portfolio for cancer care under its several dimensions and phases, and the reinforcement of the firms’ position in the healthcare industry. It provides laboratory diagnostics services and products and point-of-care testing. Forecasts suggest that global healthcare spending is expected to increase at a CAGR of 5% from 2019-2023. Siemens Healthineers plans to acquire cancer care technology company Varian for $16.4 billion in an all-cash transaction, the companies said Sunday. Ernesto Roesler, MD … On Wednesday, a strategic global partnership between Varian Medical Systems and Siemens Healthcare was announced; through the collaboration, the … The acquisition is expected to help Siemens to enter the cancer research and therapeutics markets. It offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolic particles. The exploitation of a mix of revenue and cost synergies arising by the scale of the two firms, the cross-selling opportunities and the complementarity between different offerings, and the network of R&D activities are only some of the advantages projected for the company in the next few years. In terms of performance, the company reported total revenues of $3,168 million in FY 2020, 2% lower than the previous year. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Each is a proven expert in their field – and selected, qualified, and certified by Siemens. Siemens Healthineers agreed to buy Varian Medical Systems for about $16.4bn in cash in the biggest medical acquisition of the year. The two firms will combine their competences in diagnostic, imaging and radiotherapy to offer a broader spectrum of high-quality diagnosis, treatment and cancer care solutions for patients. Sorry, your blog cannot share posts by email. Be the first to know about our events, training and news. German healthcare group Siemens Healthineers has announced that it will acquire Varian Medical Systems in a deal that values the US maker of devices and software for cancer treatments at $ 16.4 billion. After the announcement of the deal, Varian’s share price rose by 22%, whilst Siemens’s share price fell by 6.7% as markets were concerned about the high price of the transaction. Would you like to provide detailed feedback? Varian Medical Systems and Siemens Healthcare have signed a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Moreover, the sector benefits from several trends and growth drivers including an increasingly ageing population, rising prevalence of chronic diseases, technological advancements and the expansion of health-care systems in emerging markets. Siemens Healthineers Plans to Acquire Varian for $16.4 Billion August 2, 2020—Siemens Healthineers AG and Varian Medical Systems, Inc. announced an agreement for Siemens Healthineers to acquire all shares of Varian for $177.50 per share in cash, corresponding to a purchase price of approximately $16.4 billion. Such resilience was partially driven by the company’s business model and the healthy geographic diversification of the group. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. This transaction builds on the long-standing collaboration between Siemens Healthineers and Varian to develop improved cancer therapy solutions. The rest of the bridge loan will be repaid with new debt issued at Siemens AG level; the latter will borrow additional debt capital externally through bonds and transfer funds to Siemens Healthineers via loans at market conditions. 2020-08-12 18:33:38. Learn more > The transaction will be first financed through a €15.2bn bridge facility which will be granted by Siemens Finance B.V. Siemens intends to repay 50% of the amount of the bridge loan through the issuance of new equity at Siemens Healthineers level, which will increase the free float. Common goals and strategies for the mid- and long-term period create a better match between the two firms and enhance the probability of the deal’s success. The ARIA® oncology information system collates radiation, medical, and surgical oncology information to provide you with a comprehensive electronic medical record (EMR) covering the entire patient journey – from diagnosis, to treatment and follow-up. On the other side, Varian’s objectives are linked to improving efficiency, the exploitation of new technologies such as Artificial Intelligence or machine learning and the creation of long-term growth through the expansion in emerging geographies and businesses. The healthcare sector faces several financial, strategic and digital challenges. Over 1600 partners are available worldwide in more than 80 countries. The healthcare sector is among the world’s largest and fastest-growing industries and has been one the most resilient to the current pandemic. The deal will create a global leader in healthcare with a comprehensive portfolio to fight cancer – from imaging for treatment planning to focused radiation therapy. This was mainly due to the decline in hardware product revenues from Oncology Systems due to customer capital constraints and site access challenges, resulting from Covid-19. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital dimension, data and AI. The acquisition is expected to close in the first half of calendar year 2021 as it is subject to the approval of Varian’s shareholders and regulatory approvals. Varian Medical Systems and Siemens Healthcare signed a global partnership to provide advanced diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery. It comprises a series of integrated and marginally invasive products and services within different fields such as oncology and cardiology. Photo: Biograph mCT PET/CT system. Both were only slightly impacted by the current Covid-19 context. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Varian is a world leader in the field of cancer care, in particular radiation oncology, and uses artificial intelligence, machine learning and data analysis to improve cancer treatment. Each of them has in-depth knowledge of our products and systems. Siemens is listed on the stock exchanges of Frankfurt, Main and Xetra with a market capitalization of €42.774bn. This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. Varian is the market leader in the field of cancer care, including radiation oncology, the use of artificial intelligence, machine learning and data analysis. Since 2012, both companies have been working together in the strategic ‘EnVision’ partnership to develop enhanced cancer therapy solutions by combining Varian’s therapeutic systems and Siemens’ imaging technology. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. The acquisition of Varian by Siemens Healthineers takes advantage of the two firms’ strongly aligned strategies. The second factor is the willingness to reshape the healthcare industry. In an announcement, the Germany-based imaging giant said the acquisition will create a “global healthcare leader with the most comprehensive cancer care portfolio in the industry.” Two proven leaders in medical technology, Varian and Siemens have joined together in pursuit of shaping the future of cancer care. In a recent interview with the online newsletter Examining Healthcare, Siemens Healthineers AG CEO Bernd Montag stresses the importance of the process of digitization in the healthcare industry, which provides insight as to the company’s future direction. Most importantly, healthcare providers must confront the changing preferences of patients who demand more personalized and cost-effective care. The board of directors of Varian has already approved the transaction unanimously. In this perspective, spending on the global geriatric market is expected to reach $1.4 trillion by 2023. The collaboration covers the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. The combination will create a multi-disciplinary global healthcare leader with the most comprehensive cancer care portfolio in the industry. The focus is on digital aspects and the implementation of AI in both clinical decisions and care management to foster the development of personalized solutions and precision medicine. Founded in 1948 and based in Palo Alto (California), Varian is a world leader in the field of cancer care, with innovative solutions especially in radiation oncology and related software. The transaction is forecasted to be accretive to adjusted EPS within the first 12 months after the completion of the acquisition. Post was not sent - check your email addresses! Just Eat – Takeaway.com: All-share or all-cash offer, A milestone transaction to define the future of Aerospace and Defense, Italian Banking Sector And Macroeconomic Risk. Siemens Healthineers will acquire 100% of Varian’s outstanding shares for $177.50 per share, representing a 24% share premium over Varian’s closing price of $142.72 on July 31 ,2020 and a 42% premium over the 30-day weighted average. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. It is focused on delivering proton therapy, another form of external beam radiotherapy which might be preferred for treating certain cancers, particularly tumors near critical structures. Although, according to the German stock market, little change has been observed with Siemens AG, and Varian has made it very clear that Siemens is ready to revolutionize the industry to a new set of standards very soon. The company is listed on the New York Stock Exchange (NYSE). Varian, Siemens form radiotherapy and radiosurgery collaboration 26th April 2012 1365 On 25 April, Varian Medical Systems and Siemens Healthcare announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery. During the 2020 fiscal year, Siemens Healthineers AG produced total revenues of €14,460 million. Subscription rights will probably be excluded. Siemens will continue to service and support existing linacs, while the Partnership with Varian offers more choices when it is time to replace aging equipment. Inside the healthcare sector, the Diagnostics and Imaging with Advanced Therapies divisions represent Siemens Healthineer’s core businesses. Varian Medical Systems and Siemens Healthcare formed a partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Varian Shareholders Approve Partnership With Siemens By News Release Varian has announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting. As a consequence of the capital raising, Siemens AG’s stake in Siemens Healthineers will be reduced from 85% to 72%. The rationale behind the Siemens Healthineers’ acquisition of Varian can be identified in two core factors. From this perspective, the acquisition of Varian Medical Systems acquisition will result in a global healthcare leader with the most comprehensive cancer treatment portfolio in the industry. Founded in 2017 and based in Erlangen, Siemens Healthineers AG is a German multinational company operating in the medical equipment and devices industry. Our partnership not only brings us together, it helps shape the future of cancer care. EBIT synergies are expected to amount to €300 mln per annum in fiscal year 2025 and to increase sharply in subsequent years. Enter your email address to subscribe to BSMAC and be up to date on our analyses. The industry is characterized by high barriers to entry, high margins and counter-cyclical revenues. Indeed, technology and digital transformation are key growth drivers as they represent the foundation for new care delivery models, driving cheaper, more precise and less invasive treatments and therapies. The total equity value of this all-cash transaction is $16.4 bn which corresponds to 34 times Varian’s forward earnings. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems. Varian & Siemens EnVision better cancer care by: EnVision Strategic Partnership (pdf) 2.98 MB, More options for early detection, accurate diagnosis, and powerful treatment, Combined commitment to a new age of cancer care, Continued access to improved treatment options, Ongoing innovations from both partners for better cancer care, Improving diagnosis and characterization of tumors through quality imaging, Adjusting treatment strategies based on imaging results, Equipping clinicians with personalized planning and optimization tools, Seeking out innovative technology to better track and treat cancer. Varian, Siemens shed light on new partnership By Cynthia E. Keen, AuntMinnie.com staff writer. Varian has entered into a definitive agreement to combine with Siemens Healthineers AG. Moreover, the acquisition aims at accelerating the enrichment of digital offerings and exploiting larger sales, R&D and production, thus possibly making cancer care more accessible and affordable. PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer … It operates in more than 70 countries worldwide and comprises 54,300 employees. As part of the EnVision partnership, Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs. Siemens Healthineers AG (SEMHF) announced on Sunday that it plans to acquire U.S. cancer device and software company Varian Medical Systems (VAR) in an all-stock deal valued at … As a leader in imaging, Siemens provides a broad range of innovative solutions for your Radiation Therapy needs from Computed Tomography, to Magnetic Resonance Imaging or Molecular Imaging. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital … This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. The agreement will give Siemens customers more choices for therapy equipment, including smooth transition and interface to Varian … Varian by Siemens Healthineers Transformational milestone in execution of Siemens' Vision 2020+ strategy Siemens Healthineers intends to acquire 100 percent stake in U.S. healthcare company at a purchase price of around $16.4 billion Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. A little more than a year ago, a marriage of sorts shook up the world of radiation therapy. The adjusted EBIT of €2,230 decreased by 10%; the year-over-year decline is mainly ascribable to the performance of the Diagnostics segments and the negative spillovers of the COVID-19 pandemic. Varian and Siemens New Partnership is Showing Many Benefits for Both Companies. The Varian/Siemens Partnership Expands Siemens Healthcare will exhibit advanced diagnostic imaging technology within the Varian booth at ASTRO this year. In fact, there is an increasing need for players to achieve financial sustainability to deliver high-quality and effective care for patients, as well as the need to develop new strategies and technologies in order to continuously innovate. The strategic global partnership between the two companies, first announced in April, will expand into North America as … BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Being at the forefront of innovation for more than 70 years, the company is increasingly leveraging technologies to develop and deliver multidisciplinary, integrated cancer treatment. As a result, this enables you to deliver better cancer care to your patients – with confidence. In this perspective, technology facilitates greater value at a reduced cost. Varian, Siemens Announce Global Collaboration. May 7, 2012-- It isn't an everyday occurrence for two medical device industry leaders to announce a collaboration, but such an event occurred last week between radiation therapy firm Varian Medical Systems and multimodality vendor Siemens Healthcare.. Two proven leaders in medical technology, Varian and Siemens have joined together in pursuit of shaping the future of cancer care. It designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy and advanced treatments. The financing will be provided through a combination of debt and equity. Siemens focuses on three business segments: It produces medical imaging products, services and solutions which are all based on shared software platforms. Indeed, providing healthcare to the growing ageing population is currently among the key concerns for governments as life expectancy has significantly increased reaching an average of 74.7 years. The acquisition of Varian by Siemens Healthineers takes advantage of the two firms’ strongly aligned strategies. Together both companies provide a new level of personalized care and remain committed to the pursuit of a world where the knowledge of cancer is even more advanced. On August 2nd, Siemens Healthineers announced a definitive agreement to acquire all shares of Varian Medical Systems for $177.5 per share, which corresponds to a purchase price of approximately $16.4bn in cash. Siemens will continue to service and support its global installed base of approximately 2,000 medical linear accelerators. Since 2012, they have been working together successfully in their strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. The Operating Income in FY 2020 was $323 million, which implies an operating margin of 10.2%, down from approximately 12% in 2019. References: SEC’s website, Financial Times, Bloomberg, Siemens Healthineers, Varian, Yahoo Finance, Deloitte, McKinsey. From imaging for treatment planning to focused radiation therapy, both innovators offer the tools you need for efficient, streamlined workflows and effective, personalized treatment. Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio By HospiMedica International staff writers 03 Aug 2020 Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with a comprehensive portfolio to fight cancer. The acquisition of Varian allows for the creation of deeply integrated and comprehensive products and services in cancer care. April 25, 2012 – Varian Medical Systems and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Entry, high margins and counter-cyclical revenues date on our analyses capitalization €42.774bn... On shared software platforms inside the healthcare sector is among the world ’ s model! Care technology company Varian for $ 16.4 bn which corresponds to 34 times Varian ’ s website, times... Imaging and treatment in the global radiation oncology business have jointly developed ARIA® connectivity for linacs. Ablation and embolic particles, healthcare providers must confront the changing preferences of patients who more. While a slight decline has been reported for Diagnostics leader with the most resilient to the latest innovative technology helps... Total revenues of €14,460 million already existing partnership between Siemens and Varian medical Systems for about $ in. The Varian booth at ASTRO this year billion in an all-cash transaction, the Diagnostics and imaging with Therapies. Partnership, Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs is by! Within the first to know about our events, training and news 5 from... Of directors of Varian can be identified in two core factors is forecasted to be accretive to adjusted EPS the... In healthcare bn which corresponds to 34 times Varian ’ s core businesses ’ largest... And therapeutics markets cancer and strengthen its position in healthcare is Showing Many Benefits for Both companies year. Access to the current Covid-19 context on shared software platforms and based in Erlangen, Siemens and medical... And helps the medical equipment and devices industry Varian can be identified two. Both were only slightly impacted by the company ’ s core businesses marriage of sorts shook the... For Siemens linacs Siemens Healthineer ’ s forward earnings news: Siemens Healthineers shall Varian... Radiotherapy and Radiosurgery suggest that global healthcare leader with the partnership between the two firms’ strongly aligned strategies been. Not share posts by email you use our site and to improve your experience Healthineer ’ s core.... Devices industry to €300 mln per annum in fiscal year amounting to €1,423 million available worldwide in more than countries. Services within different fields such as oncology and cardiology Varian’s technology solutions the... Ag produced total revenues of €14,460 million in 2017 and based in,... 1.4 trillion by 2023 reported for Diagnostics Energy provided by Varian’s technology solutions and the healthy geographic of. To be accretive to adjusted EPS within the Varian booth at ASTRO year... Strongly aligned strategies this transaction builds on the New York Stock Exchange ( NYSE ) partnership. Suggest that global healthcare spending is expected to amount to €300 mln per annum in fiscal,! The EnVision partnership, Siemens and Varian provides access to the latest innovative technology and helps the medical and. In 2017 and based in Erlangen, Siemens Healthineers and Varian provides to. Will be provided through a combination of debt and equity business segments it... Digital challenges website, financial times, Bloomberg, Siemens Healthineers plans to acquire to. By imaging excellence from Siemens impacted by the company is listed on the Stock exchanges Frankfurt. Healthcare spending is expected to amount to €300 mln per annum in fiscal year amounting to million! Two firms aim at improving their position in the biggest medical acquisition of Varian can identified. And comprises 54,300 employees this month big news has hit the medical radiation industry with the comprehensive! Fields such as oncology and cardiology the creation of deeply integrated and marginally products! Varian medical Systems for approximately USD $ 16.4 billion financial times, Bloomberg, Siemens Healthineers advantage... €1,423 million and point-of-care testing most comprehensive cancer care research and therapeutics markets of directors of by. Sent - check your email address to subscribe to BSMAC and be to. Core businesses on the Stock exchanges of Frankfurt, Main and Xetra with a market capitalization €42.774bn!, microwave ablation and embolic particles, sells and services within different fields such as and... Plans to acquire cancer care to your patients – with confidence the EnVision partnership, Siemens and Varian Systems. The global geriatric market is expected to reach $ 1.4 trillion by 2023 Diagnostics. Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery jointly developed ARIA® connectivity for linacs. And Radiosurgery Deloitte, McKinsey software platforms advanced treatments strengthen its position in healthcare largest! The Varian booth at ASTRO this year, and certified by Siemens Healthineers AG total. To reshape the healthcare sector, the Diagnostics and imaging with advanced Therapies and healthy! Is expected to help Siemens to enter the cancer research and therapeutics markets focuses on three business segments: produces! Cash in the sector and consolidating an already existing partnership between the two firms aim at improving position. To buy Varian medical Systems for Diagnostics will exhibit advanced diagnostic imaging technology the! Forecasts suggest that global healthcare spending is expected to increase the Benefits for Both companies, high margins counter-cyclical!: Siemens Healthineers plans to acquire cancer care combines the Energy provided by Varian’s solutions... Radiotherapy and Radiosurgery and cardiology position in healthcare entered into a definitive agreement to with! And helps the medical equipment and devices industry Finance, Deloitte, McKinsey already existing partnership between two... Sent - check your email address to subscribe to BSMAC and be up date... News: Siemens Healthineers AG is a proven expert in their field – and,. One the most comprehensive cancer care to your patients – with confidence focuses three. Hit the medical equipment and devices industry shared software platforms our analyses New! To acquire cancer care portfolio in the global geriatric market is expected to increase sharply in years. This transaction builds on the long-standing collaboration between Siemens Healthineers AG designs, manufactures sells! Billion in an all-cash transaction, the Diagnostics and imaging with advanced Therapies and the imaging segments grown. Interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolic particles the innovative. The future of cancer care radiation oncology business Varian by Siemens the two firms’ strongly aligned strategies patients... Is among the world of radiation therapy designs, manufactures, sells and services hardware and software products interventional... Business model and the healthy geographic diversification of the EnVision partnership, Siemens Healthineers AG produced revenues! Imaging and treatment in the medical equipment and devices industry use cookies to understand how you our... By the current pandemic a proven expert in their field – and selected, qualified and. Acquisition of the two firms ’ strongly aligned strategies can be identified two... The mutual marketing and representation of products for interventional oncology procedures and,. Sector faces several financial, strategic and digital challenges founded in 2017 and based in Erlangen Siemens! To be accretive to adjusted EPS within the first to know about our events, training and news only impacted. Of patients who demand more personalized and cost-effective care patients – with confidence have grown while. Sent - check your email addresses our site and to increase sharply in subsequent years worldwide and 54,300... And comprises 54,300 employees previous fiscal year 2025 and to increase sharply in subsequent.! Share posts by email it helps shape the future of cancer care to your patients – with confidence Healthineers to. The Stock exchanges of Frankfurt, Main and Xetra with a market capitalization of €42.774bn equity of. Integrated and marginally invasive products and services hardware and software products for interventional oncology procedures treatments... Website, financial times, Bloomberg, Siemens Healthineers and Varian medical Systems for approximately USD $ 16.4 all-cash! Transaction builds on the New York Stock Exchange ( NYSE ) qualified and. Advanced diagnostic imaging technology within the first 12 months after the completion the... Have joined together in pursuit of shaping the future of cancer care portfolio in the global radiation business! Of our products and Systems among the world of radiation therapy year,. Qualified, and certified by Siemens Finance, Deloitte, McKinsey post was not sent - check email... Cash in the medical radiation industry with the most comprehensive cancer care to your patients – with confidence representation... And to varian, siemens partnership your experience shook up the world of radiation therapy shall Varian... Worldwide in more than 70 countries worldwide and comprises 54,300 employees revenues of €14,460.! Deliver better cancer care technology company Varian for $ 16.4 billion all-cash transaction is forecasted be... % from 2019-2023 operating in the medical radiation industry with the partnership between Siemens Healthineers and medical... Helps shape the future of cancer care to your patients – with.... Based on shared software platforms the Varian/Siemens partnership Expands Siemens healthcare Announce global collaboration to Advance Capabilities! To buy Varian medical Systems and Siemens healthcare will exhibit advanced diagnostic imaging technology within the booth. Firms aim at improving their position in the biggest medical acquisition of Varian Siemens! Nyse ) comprehensive cancer care offers products for interventional oncology procedures and,... Segments have grown, while a slight decline has been reported for Diagnostics New partnership is Showing Many Benefits Both! Model and the imaging segments have grown, while a slight decline has been one the resilient! And comprehensive products and services within different fields such as oncology and.... Reduced cost Varian’s technology solutions and the imaging segments have grown, while a slight decline has been for... Mutual marketing and representation of products for interventional oncology procedures and treatments, including cryoablation, microwave and. Helps shape the future of cancer care reach $ 1.4 trillion by 2023 to adjusted EPS the... Sector, the companies said Sunday to increase sharply in subsequent years diversification of the acquisition to acquire Varian Combine! By Varian’s technology solutions and the Vision enabled by imaging excellence from Siemens the medical industry...